Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11779576 Method of treating C3 glomerulopathy

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
February 14, 2022
Date of Patent
October 10, 2023
Patent Application Number
17670604
Patent Citations
‌
US Patent 10660897 C5aR antagonists
‌
US Patent 11285138 Method of treating C3 glomerulopathy
‌
US Patent 7105567 3-substituted urea derivatives and medicinal use thereof
‌
US Patent 7169775 Amino methyl imidazoles as C5a receptor modulators
‌
US Patent 7427615 3-substituted-4-pyrimidone derivatives
‌
US Patent 7455837 Compositions and methods for the diagnosis and treatment of sepsis
‌
US Patent 7635698 Compounds useful as chemokine receptor antagonists
‌
US Patent 7834035 Allosteric modulators of metabotropic glutamate receptors
‌
US Patent 8007767 Amino methyl imidazoles and related compounds as C5a receptor modulators
‌
US Patent 8026367 (R)-arylalkylamino derivatives and pharmaceutical compositions containing them
•••
Patent Inventor Names
Petrus Bekker
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11779576
Patent Primary Examiner
‌
James D. Anderson
CPC Code
‌
A61K 31/451
‌
A61P 13/12

Find more entities like US Patent 11779576 Method of treating C3 glomerulopathy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo